Indivior PLC
INDV | IL
Overview
Corporate Details
- ISIN(s):
- GB00BN4HT335 (+1 more)
- LEI:
- 213800V3NCQTY7IED471
- Country:
- United Kingdom
- Address:
- 234 BATH ROAD, SL1 4EE SLOUGH
- Website:
- https://www.indivior.com/en
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Indivior PLC is a leading pharmaceutical company that specializes in developing treatments for addiction and related mental health disorders. Founded in 1994, Indivior has since established itself as a global leader in the field of addiction treatment, with a presence in over 40 countries worldwide. The company's products are primarily focused on treating opioid addiction, including the development of innovative medications that help patients manage withdrawal symptoms and reduce the risk of relapse. Indivior's portfolio includes a range of medications, including Suboxone, a prescription medication used to treat opioid dependence, and Perseris, an injectable medication used to treat schizophrenia.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-17 17:42 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 26.7 KB | |
| 2025-06-13 09:10 |
Directors' Dealings
Director/PDMR Shareholding - Correction
|
English | 28.2 KB | |
| 2025-06-12 17:24 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 26.9 KB | |
| 2025-06-10 17:12 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 26.8 KB | |
| 2025-06-02 08:00 |
Delisting Announcement
Indivior Announces Intent to Cancel LSE Listing
|
English | 33.6 KB | |
| 2025-05-15 16:30 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 16.6 KB | |
| 2025-05-09 17:37 |
AGM Report
Amendment to Result of AGM
|
English | 36.1 KB | |
| 2025-05-08 15:41 |
Declaration of Voting Results & Voting Rights Announcements
Special Business Resolutions Passed at the 2025 Annual General Meeting Held on …
|
English | 35.5 KB | |
| 2025-04-22 14:58 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.6 KB | |
| 2025-03-27 15:09 |
AGM Report
Form of Proxy
|
English | 292.0 KB | |
| 2025-03-27 15:03 |
AGM Report
Notice of AGM
|
English | 847.5 KB | |
| 2025-03-17 14:56 |
Annual Report (ESEF)
Annual Report and Accounts 2024 (ESEF Version)
|
English | 8.4 MB | |
| 2025-03-17 14:56 |
Annual Report
Annual Report and Accounts 2024 (ESEF Version)
|
English | 20.1 MB | |
| 2025-03-17 14:25 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 29.4 KB | |
| 2025-03-17 14:17 |
Annual Report
Annual Financial Report
|
English | 6.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
OncoZenge AB | Sweden | ONCOZ | |
|
Orexo | Sweden | ORX | |
|
Orion Oyj | Finland | ORNAV | |
|
PAION AG | Germany | PA8 | |
|
PEPTONIC Medical AB | Sweden | PMED | |
|
Pharmanutra | Italy | PHN | |
|
PharmaSGP Holding SE | Germany | PSG | |
|
Pharmena S.A. | Poland | PHR |